Senator Patrick Leahy has urged the US National Institutes of Health (NIH) to force Myriad Genetics to license its patents directed to tests for breast and ovarian cancer.
If you have already subscribed please login.
If you have any technical issues please email tech support.
myriad genetics, senator patrick leahy, march-in rights, Bayh-Doyle Act, brca1, brca2
